Medtronic’s Infuse Bone Graft has been found to work no better than traditional bone graft surgery. To make matters worse, it has also been linked to serious side effects such as cancer, sterility and infections – causing Infuse Bone Graft patients to question why more research wasn’t done before the product was put on the market.
Risks May Outweigh Benefits
According to the Bloomberg News, although Medtronic’s Infuse Bone Graft was designed to help bones heal after spinal surgery, its risks may outweigh its benefits. Two studies recently published in the Annals of Internal Medicine revealed that the medical device works no better than a traditional surgical graft and that its associated side effects include an increased risk of cancer, male sterility and infections.
Harlan Krumholz, a Yale University professor who was in charge of the studies, which were, ironically, funded by Medtronic, said that although Infuse is less invasive than a traditional bone graft, which can require a separate surgery, the rise in cancer rates and other potential risks are worrisome. He commented:
I remain concerned that products like these are approved with too little study before they reach the market and too little afterward. There is a tremendous amount of uncertainty about the benefit it provides and how safe it is.
Many patients now suffering from Infuse side effects share his view and have filed lawsuits against the manufacturer seeking payment for medical bills, lost wages, medical monitoring, pain and suffering and more.
Medtronic Infuse Bone Graft Lawsuits
If you’ve been injured due to Medtronic’s Infuse Bone Graft medical device, contact The Driscoll Firm, P.C. Our experienced product liability attorneys have a successful track record in helping patients who have been injured by dangerous and defective medical devices. We’ve recovered over $170 million for our clients. Let us help you get the compensation you deserve.